Enovis (ENOV) Q2 2024 earnings summary

Executive summary

• Q2 2024 net sales reached $525 million, up 23% year-over-year (reported) and 5% on a comparable basis, driven by acquisitions and strong International Recon growth.

• Adjusted EBITDA margin expanded by 190 basis points to 17.2%, reflecting operational leverage, favorable mix, and acquisition contributions.

• Integration of the Lima acquisition is ahead of plan, with U.S. sales force fully aligned, international integration 70% complete, and synergy targets on track.

• Net loss from continuing operations was $18.4 million for Q2 2024, primarily due to higher transaction costs and interest expense.

• Strategic objectives for 2024 remain on track, with momentum expected to accelerate in H2 due to new product launches and cross-selling.

Financial highlights

• Q2 2024 sales were $525 million, up from $429 million in Q2 2023, representing 23% reported growth and 5% comparable growth.

• Adjusted gross margin was 59.6%, up from 58.0% year-over-year; reported gross margin was 55.0%, down due to inventory step-up amortization.

• Adjusted EBITDA was $90.2 million (17.2% margin), up from $65.7 million (15.3% margin) in Q2 2023.

• Adjusted EPS was $0.62; effective tax rate was 24% (vs. 18% prior year); interest expense rose to $17 million (from $4 million in 2023).

• Foreign currency exchange had a minor negative impact on sales and EPS.

Outlook and guidance

• Full-year 2024 revenue guidance narrowed to $2.08–$2.13 billion, with growth expected to accelerate in H2 from cross-selling and new product launches.

• Adjusted EBITDA guidance set at $368–$383 million; full-year interest expense updated to $60–$65 million after a new currency swap.

• Adjusted EPS guidance raised to $2.62–$2.77.

• Higher Q3 seasonality expected due to Lima’s international profile, with a step down in Q3 revenues and a strong Q4 rebound.

• Liquidity is sufficient to fund operations and strategic initiatives over the next twelve months.